Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Captopril: five years on.

Literature DB >> 6412854

Captopril: five years on.

G P Hodsman, J I Robertson.

Abstract

Entities: Chemical

Mesh：

Substances：
Proline
Captopril

Year: 1983 PMID： 6412854 PMCID： PMC1549299 DOI： 10.1136/bmj.287.6396.851

Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN： 0267-0623

× No keyword cloud information.

11 in total

Review 1. Captopril in the treatment of clinical hypertension and cardiac failure.

Authors: A B Atkinson; J I Robertson
Journal: Lancet Date: 1979-10-20 Impact factor: 79.321

2. Side-effects of captopril.

Authors: C G Isles; G P Hodsman; J I Robertson
Journal: Lancet Date: 1983-02-12 Impact factor: 79.321

3. Optimal dose of captopril in hypertension.

Authors: S Dombey
Journal: Lancet Date: 1983-03-05 Impact factor: 79.321

4. Optimal dose of captopril in hypertension.

Authors: S J Smith; N D Markandu; G A MacGregor
Journal: Lancet Date: 1982-12-25 Impact factor: 79.321

5. Neurological dysfunction in two patients receiving captopril and cimetidine.

Authors: A B Atkinson; J J Brown; A F Lever; D McAreavey; J I Robertson; P O Behan; I D Melville; A I Weir
Journal: Lancet Date: 1980-07-05 Impact factor: 79.321

Review 6. Medical intelligence drug therapy: captopril.

Authors: D G Vidt; E L Bravo; F M Fouad
Journal: N Engl J Med Date: 1982-01-28 Impact factor: 91.245

7. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.

Authors: A B Atkinson; A M Cumming; J J Brown; R Fraser; B Leckie; A F Lever; J J Morton; J I Robertson
Journal: Br J Clin Pharmacol Date: 1982-06 Impact factor: 4.335

Review 8. Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors: R C Heel; R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1980-12 Impact factor: 9.546

9. Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays.

Authors: S Rasmussen; M Damkjaer Nielsen; J Giese
Journal: Clin Sci (Lond) Date: 1981-05 Impact factor: 6.124

10. Factors related to first dose hypotensive effect of captopril: prediction and treatment.

Authors: G P Hodsman; C G Isles; G D Murray; T P Usherwood; D J Webb; J I Robertson
Journal: Br Med J (Clin Res Ed) Date: 1983-03-12

17 in total

1. Adverse drug reactions leading to hospital admission.

Authors: L Ibáñez; J R Laporte; X Carné
Journal: Drug Saf Date: 1991 Nov-Dec Impact factor: 5.606

Review 2. Selecting appropriate antihypertensive drug dosages.

Authors: G D Johnston
Journal: Drugs Date: 1994-04 Impact factor: 9.546

3. ACE-inhibitor-induced cough, an adverse drug reaction unrecognised for several years: studies in prescription-event monitoring.

Authors: K Kubota; N Kubota; G L Pearce; W H Inman
Journal: Eur J Clin Pharmacol Date: 1996 Impact factor: 2.953

Captopril: five years on.

Review 1. Captopril in the treatment of clinical hypertension and cardiac failure.

2. Side-effects of captopril.

3. Optimal dose of captopril in hypertension.

4. Optimal dose of captopril in hypertension.

5. Neurological dysfunction in two patients receiving captopril and cimetidine.

Review 6. Medical intelligence drug therapy: captopril.

7. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.

Review 8. Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

9. Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays.

10. Factors related to first dose hypotensive effect of captopril: prediction and treatment.

1. Adverse drug reactions leading to hospital admission.

Review 2. Selecting appropriate antihypertensive drug dosages.

3. ACE-inhibitor-induced cough, an adverse drug reaction unrecognised for several years: studies in prescription-event monitoring.

4. Pharmacokinetics of intravenous captopril in healthy men.

5. A need for new converting enzyme inhibitors?

6. Severe cutaneous reactions to captopril.

7. The risk-benefit equation: when to initiate treatment.

8. Guillain-Barré neuropathy during treatment with captopril.

9. Effect of thiol compounds on human complement component C4.

10. Captopril in severe childhood hypertension--reversible anaemia with high dosage.